Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Response to FCA Statement

28 Mar 2014 16:43

RNS Number : 5058D
Phoenix Group Holdings
28 March 2014
 



 

Phoenix Group Holdings ("Phoenix") response to FCA statement

 

 

Phoenix notes the statement issued by the FCA earlier today regarding a thematic review into the fair treatment of longstanding or legacy customers within closed life funds.

 

Although little detail has been provided regarding the scope and nature of any review, Phoenix makes the following observations:

 

· The FCA has stated that the review will not consider the suitability of historic advice, nor will it require a review of individual policies.

· The review will look at the level of servicing provided to policyholders whose policies are managed within closed life funds. Phoenix welcomes this review as we continue to look for areas where we can deliver better levels of customer service. We have achieved significant policy administration migrations to newer and better systems resulting in improved customer service. We regularly review our full product set to ensure it is operating as intended and remain committed to maintaining our focus on the governance of our products.

· Phoenix does not write new products (other than vesting annuities) and therefore we do not believe that any review of cross-subsidisation (in particular of the cost of new products) would be relevant to Phoenix.

· Furthermore, should the review look at the charging structures on historic policies, we are confident that our historic charging structures, including exit charges, have been compliant and in accordance with our commitments to our policyholders.

 

The press speculation regarding the thematic review follows two previous issues which have impacted the life assurance market over the last two weeks:

 

· The first of these issues was the announcement by the Chancellor in the Budget last week that policyholders would no longer be required to convert their pensions into an annuity on retirement. As explained in our full year results announcement, issued on Wednesday 26 March, we believe that this change will not have a material impact on Phoenix.

· Yesterday the Government announced a cap for all workplace pension schemes for auto enrolment. It is estimated that the cost of applying the cap to our schemes could have a maximum impact on our MCEV of £40 million.

 

In response to the statement from the FCA, Clive Bannister (Phoenix CEO) commented:

 

"Policyholders are central to everything that we do at Phoenix and we remain focussed on improving our performance and service. We aim to treat our policyholders fairly at all times. Operationally, we continue to streamline and modernise the business for the benefit of our policyholders. For example, in 2013 we increased the distributable estate by £565 million, with around 115,000 policyholders benefiting from £157 million of estate distributed in that year.

 

As our recent full-year results amply demonstrate, Phoenix is performing extremely well. This week we announced our highest ever cash generation (£817 million) and MCEV of £2.4 billion. We remain confident in the outlook for the Group.

 

We note that the review will not apply "current standards retrospectively" but is designed to "assess whether there is an issue that requires any action".

 

We will of course co-operate fully with any review conducted by the FCA."

 

We will update the market when we have greater clarity on the scope and nature of the review.

 

 

 

 

Enquiries

 

Investors / analysts

Sam Perowne

Head of Investor Relations, Phoenix Group

+44 (0)20 3735 0021

 

Media

Neil Bennett, Peter Ogden, Tom Eckersley,

Maitland

+44 (0)20 7379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQKFDNABKDFNB
Date   Source Headline
17th Apr 202012:00 pmRNS2020 AGM - Revised Arrangements
14th Apr 20205:15 pmRNSHolding(s) in Company
9th Apr 20204:15 pmRNSHolding(s) in Company
9th Apr 202011:00 amRNSDirector/PDMR Shareholding
31st Mar 20202:00 pmRNSTotal Voting Rights
27th Mar 20209:00 amRNSDirector/PDMR Shareholding
27th Mar 20209:00 amRNSDirector/PDMR Shareholding
23rd Mar 20204:25 pmRNSNotice of AGM
19th Mar 20205:30 pmRNSDirector/PDMR Shareholding
19th Mar 20205:30 pmRNSDirector/PDMR Shareholding
19th Mar 20205:30 pmRNSDirector/PDMR Shareholding
17th Mar 20203:00 pmRNSDirector/PDMR Shareholding
16th Mar 20205:15 pmRNSDirector/PDMR Shareholding
16th Mar 20203:30 pmRNSDirector/PDMR Shareholding
16th Mar 20203:30 pmRNSDirector/PDMR Shareholding
12th Mar 20203:45 pmRNSDirector/PDMR Shareholding
12th Mar 20203:45 pmRNSDirector/PDMR Shareholding
11th Mar 202010:30 amRNSDirector/PDMR Shareholding
10th Mar 20204:45 pmRNSHolding(s) in Company
10th Mar 20203:15 pmRNSPublication of Suppl.Prospcts
9th Mar 202012:45 pmRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSDirectorate Change
9th Mar 20207:00 amRNS2019 Annual Financial Results
3rd Mar 20205:30 pmRNSHolding(s) in Company
28th Feb 20202:30 pmRNSTotal Voting Rights
13th Feb 202010:55 amRNSResults of General Meeting
11th Feb 20207:00 amRNSBoard Changes
10th Feb 202011:00 amRNSDirector/PDMR Shareholding
31st Jan 20202:00 pmRNSTotal Voting Rights
27th Jan 20203:45 pmRNSPublication of Offering Memorandum
27th Jan 202010:00 amRNSHolding(s) in Company
24th Jan 20204:00 pmRNSHolding(s) in Company
17th Jan 20204:00 pmRNSPublication of Suppl.Prospcts
17th Jan 20203:30 pmRNSPublication of a Prospectus
8th Jan 20202:30 pmRNSDirector/PDMR Shareholding
31st Dec 20199:00 amRNSTotal Voting Rights
19th Dec 20192:00 pmRNSBlock listing Return
9th Dec 20194:00 pmRNSDirector/PDMR Shareholding
6th Dec 20197:00 amRNSProposed acquisition of ReAssure Group plc
29th Nov 20192:00 pmRNSTotal Voting Rights
28th Nov 20197:00 amRNSPhoenix Group Holdings plc - Trading Update
8th Nov 20197:00 amRNSPhoenix Group Holdings plc - Board Changes
6th Nov 20193:00 pmRNSDirector/PDMR Shareholding
31st Oct 201910:15 amRNSTotal Voting Rights
9th Oct 201912:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20192:45 pmRNSDirector/PDMR Shareholding
30th Sep 201912:15 pmRNSTotal Voting Rights
9th Sep 20194:15 pmRNSDirector/PDMR Shareholding
30th Aug 20191:15 pmRNSTotal Voting Rights
27th Aug 201911:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.